Baseline low-density lipoprotein cholesterol predicts the benefit of adding ezetimibe on statin in statin-naïve acute coronary syndrome
Abstract We aimed to evaluate the effect of baseline low-density lipoprotein cholesterol (LDL-C) on the outcomes of patients with the acute coronary syndrome (ACS) receiving pitavastatin monotherapy or the combination of pitavastatin + ezetimibe. In the HIJ-PROPER study, 1734 ACS patients with dysli...
Enregistré dans:
Auteurs principaux: | Jihaeng Im, Erisa Kawada-Watanabe, Junichi Yamaguchi, Hiroyuki Arashi, Hisao Otsuki, Yuko Matsui, Haruki Sekiguchi, Shinya Fujii, Fumiaki Mori, Hiroshi Ogawa, Nobuhisa Hagiwara |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Nature Portfolio
2021
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/55e0b3b526d3450e93a0b58908acb01c |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
Optimal Target Level of Low-density Lipoprotein Cholesterol for Vascular Function in Statin Naïve Individuals
par: Shogo Matsui, et autres
Publié: (2017) -
Similar major cardiovascular outcomes between pure statin and ezetimibe-statin in comparable intensity for type 2 diabetes with extremely atherosclerotic risks
par: Yu-Cheng Kao, et autres
Publié: (2021) -
Emerging Non-statin Treatment Options for Lowering Low-Density Lipoprotein Cholesterol
par: Chandni Bardolia, et autres
Publié: (2021) -
Prognostic effect of high-density lipoprotein cholesterol level in patients with atherosclerotic cardiovascular disease under statin treatment
par: Yi-Heng Li, et autres
Publié: (2020) -
Serum low-density lipoprotein levels, statin use, and cognition in patients with coronary artery disease
par: Rej S, et autres
Publié: (2016)